ENVERIC BIOSCIENCES, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
ENVERIC BIOSCIENCES, INC. (ENVB) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $5.70 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2018-11-14
- ENVERIC BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2018-09-30 was $5.70M.
- ENVERIC BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2018-06-30 was -$1.26M.
- ENVERIC BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2018-03-31 was -$1.57M.
- ENVERIC BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-09-30 was -$4.06M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2018-09-30 | $5.70M 10-Q · filed 2018-11-14 | $4.44M derived: sum of 2 quarters · filed 2018-11-14 | $2.87M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$1.26M 10-Q · filed 2018-08-14 | -$2.83M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$1.57M 10-Q · filed 2018-05-15 | ||
| 2017-09-30 | -$4.06M 10-Q · filed 2018-11-14 | -$7.32M derived: sum of 2 quarters · filed 2018-11-14 | -$8.05M 10-Q · filed 2018-11-14 |
| 2017-06-30 | -$3.26M 10-Q · filed 2018-08-14 | -$3.99M 10-Q · filed 2018-08-14 | |
| 2017-03-31 | -$725.50K 10-Q · filed 2018-05-15 | ||
| 2016-09-30 | -$1.78M 10-Q · filed 2017-11-13 | -$2.99M derived: sum of 2 quarters · filed 2017-11-13 | -$4.08M 10-Q · filed 2017-11-13 |
| 2016-06-30 | -$1.21M 10-Q · filed 2017-08-14 | -$2.30M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |